Implications of technology guidelines for low-income and middle-income countries

Affiliations

¹ Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi 110029, India. Electronic address: yash_deep_gupta@yahoo.co.in.
² Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi 110029, India.

Comment

Yashdeep Gupta et al. Lancet Diabetes Endocrinol. 2023 Mar.

. 2023 Mar;11(3):155.

doi: 10.1016/S2213-8587(23)00026-8. Epub 2023 Feb 2.

¹ Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi 110029, India. Electronic address: yash_deep_gupta@yahoo.co.in.
² Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi 110029, India.

No abstract available

Conflict of interest statement

We declare no competing interests.

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.
Battelino T, Alexander CM, Amiel SA, Arreaza-Rubin G, Beck RW, Bergenstal RM, Buckingham BA, Carroll J, Ceriello A, Chow E, Choudhary P, Close K, Danne T, Dutta S, Gabbay R, Garg S, Heverly J, Hirsch IB, Kader T, Kenney J, Kovatchev B, Laffel L, Maahs D, Mathieu C, Mauricio D, Nimri R, Nishimura R, Scharf M, Del Prato S, Renard E, Rosenstock J, Saboo B, Ueki K, Umpierrez GE, Weinzimer SA, Phillip M. Battelino T, et al. Lancet Diabetes Endocrinol. 2023 Jan;11(1):42-57. doi: 10.1016/S2213-8587(22)00319-9. Epub 2022 Dec 6. Lancet Diabetes Endocrinol. 2023. PMID: 36493795 Review.